“Bevacizumab Plus Chemotherapy As First-Line Treatment for Patients With Metastatic Colorectal Cancer: Results from a Spanish Observational Study”. Journal of Analytical Oncology, vol. 2, no. 3, Aug. 2013, pp.  128-134, https://doi.org/10.6000/1927-7229.2013.02.03.1.